Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase

Peripheral decarboxylase inhibitors (PDIs) prevent conversion of levodopa to dopamine in the blood by the enzyme aromatic L-amino acid decarboxylase (AADC). Alterations in enzyme activity may contribute to the required higher dosages of levodopa observed in many patients with Parkinson’s disease. We...

詳細記述

保存先:
書誌詳細
出版年:NPJ Parkinsons Dis
主要な著者: van Rumund, Anouke, Pavelka, Lukas, Esselink, Rianne A. J., Geurtz, Ben P. M., Wevers, Ron A., Mollenhauer, Brit, Krüger, Rejko, Bloem, Bastiaan R., Verbeek, Marcel M.
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979935/
https://ncbi.nlm.nih.gov/pubmed/33741988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41531-021-00172-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料